Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
In patients with type 2 diabetes who had or were at risk for atherosclerotic cardiovascular disease, treatment with dapagliflozin did not result in a higher or lower rate of MAC...
Publications
2 shownFrequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 11,672
- Institution
- The University of Texas Southwestern Medical Center
External Links
Identifiers
- ORCID
- 0000-0002-6412-7989
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.